Orchard Therapeutics plc Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD from Q4 2019 to Q4 2022

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary: Orchard Therapeutics plc quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount history and growth rate from Q4 2019 to Q4 2022.
Orchard Therapeutics plc Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending December 31, 2022 was $14.7M, a 0.03% increase year-over-year.

Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)

Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q4 2022	$14.7M	+$5K	+0.03%	Dec 31, 2022	10-K	2023-03-14
Q4 2021	$14.7M	-$3.05M	-17.2%	Dec 31, 2021	10-K	2022-03-30
Q4 2020	$17.8M	+$917K	+5.45%	Dec 31, 2020	10-K	2021-03-02
Q4 2019	$16.8M			Dec 31, 2019	10-K	2020-02-27

* An asterisk sign (*) next to the value indicates that the value is likely invalid.